- Home
- MDCX vs REFR Comparison
MDCX vs REFR Comparison
Compare MDCX & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDCX
- REFR
- Stock Information
- Founded
- MDCX 2008
- REFR 1965
- Country
- MDCX United States
- REFR United States
- Employees
- MDCX N/A
- REFR N/A
- Industry
- MDCX
- REFR Multi-Sector Companies
- Sector
- MDCX
- REFR Miscellaneous
- Exchange
- MDCX Nasdaq
- REFR Nasdaq
- Market Cap
- MDCX 50.8M
- REFR 56.9M
- IPO Year
- MDCX N/A
- REFR N/A
- Fundamental
- Price
- MDCX $2.30
- REFR $2.03
- Analyst Decision
- MDCX Strong Buy
- REFR
- Analyst Count
- MDCX 2
- REFR 0
- Target Price
- MDCX $23.50
- REFR N/A
- AVG Volume (30 Days)
- MDCX 354.3K
- REFR 127.3K
- Earning Date
- MDCX 11-22-2025
- REFR 11-06-2025
- Dividend Yield
- MDCX N/A
- REFR N/A
- EPS Growth
- MDCX N/A
- REFR N/A
- EPS
- MDCX N/A
- REFR N/A
- Revenue
- MDCX N/A
- REFR $1,222,239.00
- Revenue This Year
- MDCX N/A
- REFR N/A
- Revenue Next Year
- MDCX N/A
- REFR N/A
- P/E Ratio
- MDCX N/A
- REFR N/A
- Revenue Growth
- MDCX N/A
- REFR N/A
- 52 Week Low
- MDCX $1.79
- REFR $0.93
- 52 Week High
- MDCX $8.94
- REFR $2.70
- Technical
- Relative Strength Index (RSI)
- MDCX 45.99
- REFR 59.82
- Support Level
- MDCX $2.34
- REFR $1.60
- Resistance Level
- MDCX $2.78
- REFR $2.70
- Average True Range (ATR)
- MDCX 0.20
- REFR 0.23
- MACD
- MDCX -0.01
- REFR 0.03
- Stochastic Oscillator
- MDCX 4.00
- REFR 39.09
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
About REFR Research Frontiers Incorporated
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.